GlassScriptPhysician profile
Carley Campton
NPI 1457844482
$1,459.66
in general payments reported to CMS, 2019-2025
20 companies · $660 in 2025
The $660 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $382 · 2022: $29.44 · 2023: $76.51 · 2024: $312 · 2025: $660.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,048.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $324.25 | 2024-2025 | |
| Abbott Laboratories | $212.29 | 2021-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Amgen INC. | $195.88 | 2024-2025 | Repatha, Repatha |
| Novo Nordisk INC | $108.81 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Impulse Dynamics (USA) INC. | $108.57 | 2021 | |
| Merck Sharp & Dohme LLC | $77.58 | 2022-2025 | Verquvo |
| Alnylam Pharmaceuticals INC. | $68.41 | 2024-2025 | Amvuttra |
| Biosense Webster, INC. | $67.90 | 2021-2023 | Carto 3 |
| Boston Scientific Corporation | $47.21 | 2021 | |
| Kestra Medical Technology Services, INC. | $41.54 | 2022-2023 | Assure Wcd |
| Abiomed | $30.01 | 2024 | Impella |
| Lexicon Pharmaceuticals, INC. | $29.05 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $27.89 | 2025 | Evkeeza |
| Recor Medical INC | $25.44 | 2025 | Paradise Ultrasound Renal Denervation System |
| Cvrx, INC. | $22.57 | 2025 | Barostim Neo System |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $17.94 | 2025 | Wainua |
| Esperion Therapeutics, INC. | $16.02 | 2024 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.69 | 2024 | Jardiance |
| Medtronic, INC. | $13.47 | 2023 | Linq II |
| Corium, LLC | $9.14 | 2025 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carley Campton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.